血清素1A (5-HT1A) 受体作为抑郁症的药理目标
Alexander L W Smith1,2, Catherine J Harmer1,2, Philip J Cowen1,2
1Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK.
CNS drugs
|June 29, 2023
概括
一项新的研究探索了血清素1A (5-HT1A) 受体.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 临床抑郁症是一种异质性疾病,对许多人来说治疗方法不足.
- 血清素1A (5-HT1A) 受体与抑郁症的病理生理学有关.
- 像SSRI这样的现有抗抑郁药延迟了治疗效果,可能是由于5-HT1A自身受体.
研究的目的:
- 审查5HT1A受体在抑郁症中的作用.
- 探索前和后突触5-HT受体在抑郁症中的不同作用.
- 讨论针对5-HT1A受体的新型治疗策略,例如偏向激烈症.
主要方法:
- 这是一个叙事评论.
- 检查了涉及5-HT1A受体在抑郁症和抗抑郁作用中的证据.
- 实验医学方法和神经认知模型被建议用于未来的研究.
主要成果:
- 前和后突触5-HT1A受体可能在抑郁症中起着不同的作用.
- 人类特异性药理学探针的有限可用性阻碍了治疗的发展.
- 5-HT1A偏向的激动症为向药物开发提供了一个有希望的途径.
结论:
- 了解5-HT1A受体亚型的差异性作用对于推进抑郁症治疗至关重要.
- 需要新的方法,如偏见的激进主义和实验医学研究,以开发更有效的疗法.
- 针对5-HT1A受体提供了一种潜在的途径,以克服目前抑郁症治疗的局限性.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
277
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
277
G-protein Coupled Receptors
120.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.3K
Antidepressant Drugs: Overview
597
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
597
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
445
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
445
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
314
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
314
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


